(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Idera Pharmaceuticals, iShares FTSE EPRA/NAREIT Europe, and Ideal Power.

Rank Financial Asset Price Change Updated (EST)
1 Idera Pharmaceuticals (IDRA) 0.52 7.57% 2022-05-23 19:42:14
2 iShares FTSE EPRA/NAREIT Europe (IFEU) 35.08 7.21% 2022-05-23 19:48:12
3 Ideal Power (IPWR) 11.61 5.55% 2022-05-23 22:55:14
4 Mannatech (MTEX) 23.70 5.33% 2022-05-24 15:11:06
5 II-VI Incorporated (IIVI) 61.83 4.65% 2022-05-23 21:07:06
6 LPL Financial Holdings (LPLA) 183.68 3.87% 2022-05-24 07:13:06
7 Globalstar (GSAT) 1.22 3.85% 2022-05-24 05:40:48
8 Spectra Energy (SE) 79.66 3.6% 2022-05-24 11:36:57
9 Pfizer (PFE) 52.47 3.59% 2022-05-24 10:49:00
10 Insmed (INSM) 20.25 3.47% 2022-05-23 22:07:20

The three most active and biggest losers today are Ross Stores, Burlington Stores, and SemiLEDS Corporation.

Rank Financial Asset Price Change Updated (EST)
1 Ross Stores (ROST) 71.87 -22.47% 2022-05-24 11:36:33
2 Burlington Stores (BURL) 150.71 -14.95% 2022-05-24 11:11:48
3 SemiLEDS Corporation (LEDS) 2.33 -8.63% 2022-05-24 05:07:20
4 Marinus Pharmaceuticals (MRNS) 5.01 -8.41% 2022-05-24 15:08:07
5 Mirati Therapeutics (MRTX) 58.80 -7.52% 2022-05-24 15:09:06
6 Shopify (SHOP) 363.85 -7.02% 2022-05-24 13:51:29
7 Lifeway Foods (LWAY) 5.10 -6.59% 2022-05-24 07:47:13
8 Kopin Corporation (KOPN) 1.17 -6.4% 2022-05-24 03:11:05
9 Gladstone Land Corporation (LAND) 23.15 -5.66% 2022-05-24 03:49:15
10 Materialise NV (MTLS) 14.37 -5.58% 2022-05-24 15:12:06

Most Active Winners today

1. Idera Pharmaceuticals (IDRA) – 7.57%

Idera Pharmaceuticals, Inc. is a biopharmaceutical company at the clinical stage. It specializes in developing and marketing drugs for rare diseases and oncology. Tilsotolimod, a synthetic phosphorothioate oligonucleotide, is offered by the company (IMO-2125). It acts as an agonist for TLR9 and stimulates the immune system. AbbVie Inc. has signed a supply and collaboration agreement. Idera Pharmaceuticals, Inc., was founded in 1989. It is located in Exton, Pennsylvania.

NASDAQ ended the session with Idera Pharmaceuticals rising 7.57% to $0.52 on Tuesday while NASDAQ dropped 0.3% to $11,354.62.

Volume

Today’s last reported volume for Idera Pharmaceuticals is 1076780 which is 6.82% above its average volume of 1007960.

Idera Pharmaceuticals’s last close was $0.52, 69.59% below its 52-week high of $1.71.

The company’s growth estimates for the current quarter is a negative 104.1% and positive 26.7% for the next.

Idera Pharmaceuticals’s Stock Yearly Top and Bottom Value

Idera Pharmaceuticals’s stock is valued at $0.52 at 17:32 EST, way under its 52-week high of $1.71 and way above its 52-week low of $0.30.

Idera Pharmaceuticals’s Moving Average

Idera Pharmaceuticals’s worth is way above its 50-day moving average of $0.47 and way below its 200-day moving average of $0.70.

More news about Idera Pharmaceuticals.

2. iShares FTSE EPRA/NAREIT Europe (IFEU) – 7.21%

NASDAQ ended the session with iShares FTSE EPRA/NAREIT Europe jumping 7.21% to $35.08 on Tuesday, after five consecutive sessions in a row of losses. NASDAQ dropped 0.3% to $11,354.62, following the last session’s upward trend on what was a somewhat negative trend trading session today.

More news about iShares FTSE EPRA/NAREIT Europe.

3. Ideal Power (IPWR) – 5.55%

Ideal Power Inc. is focused on commercialization and development of the B-TRAN technology. The company develops bi-directional bipolar junction TRANsistor solid-state switch technology. The original name of the company was Ideal Power Converters Inc., but it changed its name in July 2013 to Ideal Power Inc. Ideal Power Inc. was founded in 2007, and has its headquarters in Austin, Texas.

NASDAQ ended the session with Ideal Power jumping 5.55% to $11.61 on Tuesday, following the last session’s upward trend. NASDAQ fell 0.3% to $11,354.62, following the last session’s upward trend on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Ideal Power is 47216 which is 34.77% above its average volume of 35033.

Ideal Power’s last close was $11.61, 35.79% under its 52-week high of $18.08.

Ideal Power’s Sales

Ideal Power’s sales growth is 135.3% for the present quarter and 65.3% for the next. The company’s growth estimates for the present quarter and the next is a negative 42.1% and a negative 70%, respectively.

Ideal Power’s Revenue

Year-on-year quarterly revenue growth declined by 48.4%, now sitting on 459.35k for the twelve trailing months.

Ideal Power’s Stock Yearly Top and Bottom Value

Ideal Power’s stock is valued at $11.61 at 17:32 EST, way below its 52-week high of $18.08 and way above its 52-week low of $7.01.

Ideal Power’s Moving Average

Ideal Power’s worth is way higher than its 50-day moving average of $8.67 and under its 200-day moving average of $11.62.

More news about Ideal Power.

4. Mannatech (MTEX) – 5.33%

Mannatech, Incorporated is a global health and wellbeing company. The company develops and markets nutritional supplements, topical, skin, anti-aging, weight management products, as well as other products. It sells its products mainly directly as well through network marketing channels. The website is also used. Mannatech, Incorporated, was established in 1993. It is located in Flower Mound, Texas.

NASDAQ ended the session with Mannatech jumping 5.33% to $23.70 on Tuesday, after five successive sessions in a row of losses. NASDAQ slid 0.3% to $11,354.62, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Mannatech is 5362 which is 11.66% below its average volume of 6070.

Mannatech’s last close was $22.79, 53.57% under its 52-week high of $49.08.

Mannatech’s Revenue

Year-on-year quarterly revenue growth declined by 15.5%, now sitting on 153.83M for the twelve trailing months.

Mannatech’s Stock Yearly Top and Bottom Value

Mannatech’s stock is valued at $23.70 at 17:32 EST, way below its 52-week high of $49.08 and way above its 52-week low of $19.75.

Mannatech’s Moving Average

Mannatech’s value is way below its 50-day moving average of $32.67 and way below its 200-day moving average of $34.97.

More news about Mannatech.

5. II-VI Incorporated (IIVI) – 4.65%

II-VI Incorporated designs, produces, and sells optoelectronic devices and components worldwide. Two segments of the company are Compound Semiconductors or Photonic Solutions. Compound Semiconductors offers optical components and other materials for high-power CO2 lasers, fiber-delivered beam delivery system and processing tools. It also provides direct diode lasers and processing tools to industrial lasers. Infrared components, optical assemblies, and infrared optics are also offered by this segment. This includes semiconductor lasers, detectors, for InP optical interconnects, sensing, and semiconductor markets. It also offers compound semiconductor epitaxial (CSE) wafers that can be used in optical components, wireless devices and communication systems. Photonic Solutions provides optical materials, optoelectronic module, crystal materials and microchip lasers for commercial and consumer applications. The segment offers optical isolators and pump lasers as well as optical amplifiers and microoptics that can be used in optical amplifiers. Original equipment manufacturers and laser end users are served by the company. U.S. Government prime contractors and other U.S. agencies also serve as U.S. manufacturers and suppliers of equipment and devices used in industrial, optical communications and consumer electronics as well as security, monitoring, and surveillance applications. The headquarters of the company is in Saxonburg in Pennsylvania.

NASDAQ ended the session with II-VI Incorporated rising 4.65% to $61.83 on Tuesday, after two successive sessions in a row of gains. NASDAQ fell 0.3% to $11,354.62, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for II-VI Incorporated is 1598900 which is 17.13% above its average volume of 1364980.

II-VI Incorporated’s last close was $61.83, 17.81% below its 52-week high of $75.23.

II-VI Incorporated’s Sales

II-VI Incorporated’s sales growth is 6.4% for the ongoing quarter and 8.8% for the next. The company’s growth estimates for the present quarter and the next is 6.8% and 16.1%, respectively.

II-VI Incorporated’s Revenue

Year-on-year quarterly revenue growth grew by 5.7%, now sitting on 3.24B for the twelve trailing months.

II-VI Incorporated’s Stock Yearly Top and Bottom Value

II-VI Incorporated’s stock is valued at $61.83 at 17:32 EST, way under its 52-week high of $75.23 and way higher than its 52-week low of $54.35.

II-VI Incorporated’s Moving Average

II-VI Incorporated’s value is below its 50-day moving average of $65.50 and under its 200-day moving average of $64.42.

More news about II-VI Incorporated.

6. LPL Financial Holdings (LPLA) – 3.87%

LPL Financial Holdings Inc. and its subsidiaries offer integrated brokerage and investment advisory services for independent financial advisers as well as financial advisors working at financial institutions across the United States. Fixed and variable annuities as well as mutual funds and equities are available. Retirement and education savings plans can also be offered. Insurance, alternative investments such as business development companies and non-traded real property investment trusts, may all be included in the brokerage offering. It also offers advisory platforms which allow access to mutual funds and exchange-traded money, stocks, bonds and certain options strategies. It also offers money market services and retirement solutions that are commission- and fee-based. This allows advisors to offer brokerage, consulting, and advice for retirement plan sponsors. The company also offers other services, including tools and services that allow advisors to grow and maintain their practice; trust, investment oversight and custodial service to trusts for families and estates; as well as general agency and insurance services. It also provides technology products such as portfolio modeling, proposal generation and investment analytics. LPL Investment Holdings Inc. was the company’s previous name. In June 2012, it changed its name from LPL Financial Holdings Inc. LPL Financial Holdings Inc. is located in San Diego, California.

NASDAQ ended the session with LPL Financial Holdings rising 3.87% to $183.68 on Tuesday while NASDAQ fell 0.3% to $11,354.62.

Volume

Today’s last reported volume for LPL Financial Holdings is 981891 which is 7.43% above its average volume of 913954.

LPL Financial Holdings’s last close was $183.68, 16.81% below its 52-week high of $220.80.

LPL Financial Holdings’s Sales

LPL Financial Holdings’s sales growth is 11.9% for the current quarter and 9.3% for the next. The company’s growth estimates for the present quarter and the next is 9.2% and 46.9%, respectively.

LPL Financial Holdings’s Revenue

Year-on-year quarterly revenue growth grew by 21%, now sitting on 8.08B for the twelve trailing months.

LPL Financial Holdings’s Stock Yearly Top and Bottom Value

LPL Financial Holdings’s stock is valued at $183.68 at 17:32 EST, way below its 52-week high of $220.80 and way higher than its 52-week low of $127.03.

LPL Financial Holdings’s Moving Average

LPL Financial Holdings’s worth is below its 50-day moving average of $186.59 and higher than its 200-day moving average of $168.89.

More news about LPL Financial Holdings.

7. Globalstar (GSAT) – 3.85%

NYSE ended the session with Globalstar rising 3.85% to $1.22 on Tuesday while NYSE rose 0.3% to $15,080.98.

Volume

Today’s last reported volume for Globalstar is 2564940 which is 45.77% below its average volume of 4730480.

Globalstar’s Sales

Globalstar’s sales growth is a negative 13.3% for the ongoing quarter and a decline by 13.7% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Globalstar’s stock is considered to be oversold (<=20).

More news about Globalstar.

8. Spectra Energy (SE) – 3.6%

Sea Limited is involved in digital entertainment and e-commerce in Southeast Asia and Latin America. It also offers digital financial services businesses internationally. Garena is a digital entertainment platform that allows users to play online mobile games and eSports. It also provides access to entertainment content such as gameplay livestreaming and other social features such as chat and forums. Shopee is an e-commerce platform that operates on mobile devices. It offers integrated logistics and payment infrastructure as well as seller services. It also offers SeaMoney digital services to businesses and individuals, such as e-wallets and payment services AirPay and ShopeePay and ShopeePayLater; payment processing for Shopee. Sea Limited was previously known as Garena Interactive Holding Limited. It changed its name in April 2017 to Sea Limited. Sea Limited was established in Singapore in 2009.

NYSE ended the session with Spectra Energy rising 3.6% to $79.66 on Tuesday while NYSE jumped 0.3% to $15,080.98.

Volume

Today’s last reported volume for Spectra Energy is 11188200 which is 21.16% above its average volume of 9234060.

Spectra Energy’s last close was $77.25, 79.27% under its 52-week high of $372.70.

Spectra Energy’s Sales

Spectra Energy’s sales growth is 58.9% for the ongoing quarter and 64.9% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 42.7% and a negative 51.8%, respectively.

Spectra Energy’s Revenue

Year-on-year quarterly revenue growth grew by 105.7%, now sitting on 9.96B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Spectra Energy’s stock is considered to be oversold (<=20).

Spectra Energy’s Stock Yearly Top and Bottom Value

Spectra Energy’s stock is valued at $79.66 at 17:32 EST, way under its 52-week high of $372.70 and way above its 52-week low of $54.06.

Spectra Energy’s Moving Average

Spectra Energy’s worth is way under its 50-day moving average of $98.60 and way below its 200-day moving average of $218.50.

More news about Spectra Energy.

9. Pfizer (PFE) – 3.59%

Pfizer Inc. is a global manufacturer and distributor of healthcare products. Pfizer Inc. develops, manufactures and sells healthcare products worldwide. It also offers vaccines and medicines in a variety of therapeutic areas such as meningococcal and pneumococcal diseases, tick-borne encephalitis, and FSME/IMMUN under Prevnar 13/Prevenar 13 (pediatric/adult), FSME/IMMUN, Nimenrix and Trumenba brand names; biosimilars under the Xeljanz and Enbrel brands for chronic immune or inflammatory conditions; amyloidosamax/Xynthamax and Genotropin and Refacto AF/Xynthamax and Genotropin and Refacto AF/Xynthamax brands. The company also has a contract manufacturing division. The company serves hospitals, clinics and government agencies as well as individual providers offices and disease prevention and control centers. Astellas Pharma US, Inc. and Bristol-Myers Squibb Company have co-promotion and collaboration agreements. Verily Life Sciences LLC has a licensing arrangement with Akcea Therapeutics, Inc. Collaboration agreements with Merck KGaA, Valneva SE, and a clinical trial collaboration with IDEAYA Biosciences, Inc. Material transfer and collaboration agreement between BioNTech SE. A clinical supply collaboration is with Jiangsu Alphamab Biopharmaceuticals Co., Ltd., and a license agreement and research agreement and with BioInvent International AB. Pfizer Inc. was established in New York in 1849.

NYSE ended the session with Pfizer rising 3.59% to $52.47 on Tuesday while NYSE jumped 0.3% to $15,080.98.

Volume

Today’s last reported volume for Pfizer is 29522900 which is 6.62% above its average volume of 27687800.

Pfizer’s last close was $52.88, 14.31% below its 52-week high of $61.71.

News about Pfizer today

  • Coronavirus tally: FDA advisory panel to meet June 15 to discuss Pfizer, biontech and Moderna vaccines for children aged 6 months to 4 years. According to today’s article on MarketWatch, "The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer Inc. and German partner BioNTech SE as well as the one developed by Moderna Inc. in children aged 6 months to four years old. ", "The announcement came after Pfizer and BioNTech said three doses of their vaccine proved 80% effective at preventing symptomatic infections in children in that cohort. "

Pfizer’s Sales

Pfizer’s sales growth is 40.9% for the present quarter and 8.9% for the next. The company’s growth estimates for the ongoing quarter and the next is 89.7% and 41%, respectively.

Pfizer’s Revenue

Year-on-year quarterly revenue growth grew by 106.8%, now sitting on 81.29B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pfizer’s stock is considered to be oversold (<=20).

Pfizer’s Stock Yearly Top and Bottom Value

Pfizer’s stock is valued at $52.47 at 17:32 EST, way under its 52-week high of $61.71 and way higher than its 52-week low of $38.48.

Pfizer’s Moving Average

Pfizer’s worth is higher than its 50-day moving average of $51.32 and above its 200-day moving average of $49.82.

Previous days news about Pfizer

  • Pfizer, biontech Covid-19 vaccine for children aged 6 months to 5 years meets EUA criteria. According to MarketWatch on Monday, 23 May, "Shares of Pfizer Inc. rose 0.3% and BioNTech SE rallied 1.3% in premarket trading, after the drug makers said three doses of it COVID-19 vaccine for children aged six months to five years "met all immunobridging criteria" required for Emergency Use Authorization by the U.S. Food and Drug Administration. "

More news about Pfizer.

10. Insmed (INSM) – 3.47%

Insmed Incorporated is a biopharmaceutical firm that develops and markets therapies for patients suffering from rare and serious diseases. As part of a combined antibacterial regimen, the company also offers ARIKAYCE to treat Mycobacterium avium lung disease. Brensocatib is an oral reversible inhibiter of dipeptidyl protease 1, which can be used to treat patients suffering from bronchiectasis or other neutrophil-mediated disorders. Treprostinil Palitil Inhalation powder, which inhaled a prodrug of Treprostinil palmitil, will also be developed. It’s also working on Brensocatib for treatment of patients suffering from pulmonary arterial hypertension. It was established in Bridgewater in New Jersey in 1988.

NASDAQ ended the session with Insmed rising 3.47% to $20.25 on Tuesday while NASDAQ dropped 0.3% to $11,354.62.

Volume

Today’s last reported volume for Insmed is 1214100 which is 11.7% above its average volume of 1086920.

Insmed’s last close was $20.25, 41.2% below its 52-week high of $34.44.

The company’s growth estimates for the present quarter and the next is 15.9% and 7.3%, respectively.

Insmed’s Revenue

Year-on-year quarterly revenue growth grew by 35.5%, now sitting on 188.46M for the twelve trailing months.

Insmed’s Stock Yearly Top and Bottom Value

Insmed’s stock is valued at $20.25 at 17:32 EST, way under its 52-week high of $34.44 and way higher than its 52-week low of $16.41.

Insmed’s Moving Average

Insmed’s value is under its 50-day moving average of $22.46 and way under its 200-day moving average of $25.38.

More news about Insmed.

Most Active Losers Today

1. Ross Stores (ROST) – -22.47%

Ross Stores, Inc., along with its affiliates, operate off-price home fashion and apparel stores under the Ross Dress for Less brands and dd’s DISCOUNTS. The company’s retail stores sell primarily apparel, footwear, accessories and home fashions. Ross Dress for Less is a company store that sells its products in specialty and department stores. Its Ross Dress for Less stores are primarily for middle-income households. dd’s DISCOUNTS stores sell their products in department stores and discount shops at regular prices for customers with moderate income. It had approximately 1,850 home and fashion shops and apparel at reduced prices in forty states and the District of Columbia as of February 3, 2021. It was established in 1982 in Dublin, California.

NASDAQ ended the session with Ross Stores falling 22.47% to $71.87 on Tuesday while NASDAQ dropped 0.3% to $11,354.62.

Volume

Today’s last reported volume for Ross Stores is 34575500 which is 820.37% above its average volume of 3756690.

Ross Stores’s last close was $78.75, 38.27% below its 52-week high of $127.58.

The company’s growth estimates for the current quarter and the next is a negative 25.4% and a negative 2.9%, respectively.

Ross Stores’s Revenue

Year-on-year quarterly revenue growth grew by 18.1%, now sitting on 18.92B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Ross Stores’s stock is considered to be overbought (>=80).

Ross Stores’s Stock Yearly Top and Bottom Value

Ross Stores’s stock is valued at $71.87 at 17:32 EST, way under its 52-week high of $127.58 and above its 52-week low of $69.75.

Ross Stores’s Moving Average

Ross Stores’s worth is way under its 50-day moving average of $95.46 and way under its 200-day moving average of $105.46.

More news about Ross Stores.

2. Burlington Stores (BURL) – -14.95%

Burlington Stores, Inc. is a US retailer for branded apparel. It offers fashion-focused products, such as women’s ready to wear apparel, accessories and footwear as well as youth apparel, coats and toys. Burlington Stores is the company’s main brand. It has 736 locations in 45 states and Puerto Rico. Burlington is the headquarters of this company, which was established in 1972.

NYSE ended the session with Burlington Stores dropping 14.95% to $150.71 on Tuesday, after four consecutive sessions in a row of gains. NYSE rose 0.3% to $15,080.98, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Burlington Stores is 4005790 which is 276.09% above its average volume of 1065090.

Burlington Stores’s last close was $155.45, 56.5% under its 52-week high of $357.34.

Burlington Stores’s Sales

Burlington Stores’s sales growth is 33.9% for the ongoing quarter and 19.5% for the next. The company’s growth estimates for the current quarter and the next is 344.8% and 39.3%, respectively.

Burlington Stores’s Revenue

Year-on-year quarterly revenue growth grew by 119%, now sitting on 8.35B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Burlington Stores’s stock is considered to be overbought (>=80).

Burlington Stores’s Stock Yearly Top and Bottom Value

Burlington Stores’s stock is valued at $150.71 at 17:32 EST, way below its 52-week low of $229.53.

Burlington Stores’s Moving Average

Burlington Stores’s value is way below its 50-day moving average of $280.61 and way under its 200-day moving average of $307.57.

More news about Burlington Stores.

3. SemiLEDS Corporation (LEDS) – -8.63%

SemiLEDs Corporation designs, produces, and markets light emitting diode chips and components. It also sells LED modules and systems internationally. It also offers enhanced vertical LED products in white, green and ultraviolet; LED chips for packagers and distributors; as well as lighting products that are primarily designed to be used by original designers of lighting products. The company packages its LED chips and distributes them to end-users. The company’s products can be used in general lighting applications such as commercial, industrial and residential lighting. It also sells LED chips to packagers or distributors. SemiLEDs Corporation was established in 2005 in Chunan (Taiwan).

NASDAQ ended the session with SemiLEDS Corporation sliding 8.63% to $2.33 on Tuesday while NASDAQ dropped 0.3% to $11,354.62.

Volume

Today’s last reported volume for SemiLEDS Corporation is 21777 which is 87.79% below its average volume of 178396.

SemiLEDS Corporation’s last close was $2.32, 92.62% below its 52-week high of $31.44.

SemiLEDS Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 80.4%, now sitting on 6.45M for the twelve trailing months.

SemiLEDS Corporation’s Stock Yearly Top and Bottom Value

SemiLEDS Corporation’s stock is valued at $2.33 at 17:32 EST, way under its 52-week high of $31.44 and way above its 52-week low of $2.05.

SemiLEDS Corporation’s Moving Average

SemiLEDS Corporation’s worth is way under its 50-day moving average of $3.06 and way below its 200-day moving average of $5.45.

More news about SemiLEDS Corporation.

4. Marinus Pharmaceuticals (MRNS) – -8.41%

Marinus Pharmaceuticals, Inc. is a pharmaceutical company in clinical stages. It focuses its efforts on the development and commercialization of therapeutics for rare seizure disorders. Ganaxolone is a clinical-stage product candidate. It’s an allosteric moderator of GABAA. The company has developed formulations that can be administered intravenously (IV), or oral to adult and children patients in both acute and chronic care settings. Ganaxolone, the company’s product candidate, is an anti-seizure and antidepressant that acts at both synaptic GABAA and extrasynaptic GABAA channels. The company is currently developing ganaxolone to treat status epilepticus and cyclin dependentkinase such as PCDH19-related epilepsy. Tuberous sclerosis complex and postpartum depression. Marinus Pharmaceuticals, Inc. is a licensed partner of CyDex Pharmaceuticals, Inc. and Purdue Neuroscience Company. Radnor is the headquarters of this company, which was founded in 2003.

NASDAQ ended the session with Marinus Pharmaceuticals dropping 8.41% to $5.01 on Tuesday while NASDAQ dropped 0.3% to $11,354.62.

Volume

Today’s last reported volume for Marinus Pharmaceuticals is 191664 which is 51.2% below its average volume of 392800.

Marinus Pharmaceuticals’s last close was $5.47, 72.42% below its 52-week high of $19.83.

Marinus Pharmaceuticals’s Sales

Marinus Pharmaceuticals’s sales growth is a negative 14.3% for the ongoing quarter and 36.9% for the next. The company’s growth estimates for the ongoing quarter is a negative 6.2% and positive 13.2% for the next.

Marinus Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 685.5%, now sitting on 27.73M for the twelve trailing months.

Marinus Pharmaceuticals’s Stock Yearly Top and Bottom Value

Marinus Pharmaceuticals’s stock is valued at $5.01 at 17:33 EST, way below its 52-week high of $19.83 and way above its 52-week low of $4.19.

Marinus Pharmaceuticals’s Moving Average

Marinus Pharmaceuticals’s worth is way under its 50-day moving average of $7.60 and way under its 200-day moving average of $10.32.

More news about Marinus Pharmaceuticals.

5. Mirati Therapeutics (MRTX) – -7.52%

Mirati Therapeutics, Inc., is a clinical stage oncology company that develops products to target the immunological and genetic promoters for cancer in America. MRTX849 is a KRAS G12C inhibit that’s currently in Phase I/II clinical trials for non-small-cell lung cancer (NSCL), colorectal and pancreatic cancers. Sitravatinib is an investigational spectrum-selective kinase kinase inhibitor. It is also in Phase II clinical trials for the treatment of NSCL. A KRAS G12D program is still in preclinical development. The company has a license and collaboration agreement with BeiGene, Ltd. for sitravatinib development, manufacturing, and marketing. It also has a clinical collaboration agreement to Novartis Pharmaceuticals Corporation. Mirati Therapeutics, Inc., was established in 1995. It is located in San Diego, California.

NASDAQ ended the session with Mirati Therapeutics falling 7.52% to $58.80 on Tuesday while NASDAQ dropped 0.3% to $11,354.62.

Volume

Today’s last reported volume for Mirati Therapeutics is 501207 which is 29.27% below its average volume of 708713.

Mirati Therapeutics’s last close was $63.58, 67.56% below its 52-week high of $195.99.

The company’s growth estimates for the ongoing quarter and the next is a negative 7.7% and a negative 131.6%, respectively.

Mirati Therapeutics’s Stock Yearly Top and Bottom Value

Mirati Therapeutics’s stock is valued at $58.80 at 17:33 EST, way below its 52-week high of $195.99 and way higher than its 52-week low of $51.16.

Mirati Therapeutics’s Moving Average

Mirati Therapeutics’s worth is way under its 50-day moving average of $72.76 and way under its 200-day moving average of $124.32.

More news about Mirati Therapeutics.

6. Shopify (SHOP) – -7.02%

Shopify Inc. is a commerce company that offers a multi-channel cloud commerce platform to small and medium businesses across Canada, Australia, the United States and the United Kingdom. The platform gives merchants a single view into their business and customers across all sales channels. This includes Web and mobile storesfronts as well as physical locations and social media outlets. It also allows them to process orders and pay, ship and fulfill orders, manage inventory and products, create customer relationships and leverage analytics. Formerly known as Jaded Pixel Technologies Inc., Shopify Inc. was established in November 2011. Shopify Inc. was established in 2004. It is located in Ottawa, Canada.

NYSE ended the session with Shopify sliding 7.02% to $363.85 on Tuesday, following the last session’s upward trend. NYSE jumped 0.3% to $15,080.98, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Shopify is 5614350 which is 40.27% above its average volume of 4002260.

Shopify’s last close was $368.49, 79.1% below its 52-week high of $1,762.92.

The company’s growth estimates for the ongoing quarter and the next is a negative 83% and a negative 76.9%, respectively.

Shopify’s Revenue

Year-on-year quarterly revenue growth grew by 41.1%, now sitting on 4.61B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Shopify’s stock is considered to be overbought (>=80).

Shopify’s Stock Yearly Top and Bottom Value

Shopify’s stock is valued at $363.85 at 17:33 EST, way under its 52-week high of $1,762.92 and way higher than its 52-week low of $308.06.

Shopify’s Moving Average

Shopify’s value is way under its 50-day moving average of $540.69 and way below its 200-day moving average of $1,096.98.

More news about Shopify.

7. Lifeway Foods (LWAY) – -6.59%

Lifeway Foods, Inc. markets and produces probiotic-based products both in the United States as well as internationally. Drinkable Kefir is its primary product. It’s a cultured dairy product that comes in many flavors and sizes. It also sells European-style soft cheeses and cream, as well as ProBugs, which are kefir products for kids. The company sells products under the brand names Lifeway and Fresh Made. It also offers private labels for customers through its direct sales team, brokers and distributors. It was established in 1986 in Morton Grove in Illinois.

NASDAQ ended the session with Lifeway Foods dropping 6.59% to $5.10 on Tuesday, following the last session’s upward trend. NASDAQ dropped 0.3% to $11,354.62, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for Lifeway Foods is 3445 which is 87.32% below its average volume of 27185.

Lifeway Foods’s last close was $5.17, 42.56% under its 52-week high of $9.00.

Lifeway Foods’s Sales

Lifeway Foods’s sales growth is a negative 14.6% for the present quarter and a decline by 15% for the next.

Lifeway Foods’s Revenue

Year-on-year quarterly revenue growth grew by 13.5%, now sitting on 113.68M for the twelve trailing months.

Lifeway Foods’s Stock Yearly Top and Bottom Value

Lifeway Foods’s stock is valued at $5.10 at 17:33 EST, way below its 52-week high of $9.00 and way above its 52-week low of $4.55.

Lifeway Foods’s Moving Average

Lifeway Foods’s worth is way below its 50-day moving average of $6.39 and under its 200-day moving average of $5.65.

More news about Lifeway Foods.

8. Kopin Corporation (KOPN) – -6.4%

Kopin Corporation and its subsidiaries invent, develop, manufacture, sell components and subassemblies. They also make and market hand-held and head-worn systems throughout the United States and Europe. The company offers liquid crystal on silicone displays/spatial lights modulators and miniature active-matrix liquid clear crystal displays; as well as optical lenses, headset systems, backlights and application specific integrated circuits. Its products can be used for soldier, avionic and armored vehicle training and simulation defense applications. Kopin Corporation was founded in 1984. It is located in Westborough in Massachusetts.

NASDAQ ended the session with Kopin Corporation sliding 6.4% to $1.17 on Tuesday, after two sequential sessions in a row of losses. NASDAQ fell 0.3% to $11,354.62, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Kopin Corporation is 449748 which is 66.2% below its average volume of 1330940.

Kopin Corporation’s last close was $1.17, 88.45% below its 52-week high of $10.13.

The company’s growth estimates for the ongoing quarter is 25% and a drop 100% for the next.

Kopin Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 0.8%, now sitting on 45.57M for the twelve trailing months.

Kopin Corporation’s Stock Yearly Top and Bottom Value

Kopin Corporation’s stock is valued at $1.17 at 17:33 EST, way under its 52-week high of $10.13 and way above its 52-week low of $1.05.

Kopin Corporation’s Moving Average

Kopin Corporation’s worth is way under its 50-day moving average of $1.96 and way below its 200-day moving average of $3.90.

More news about Kopin Corporation.

9. Gladstone Land Corporation (LAND) – -5.66%

Gladstone Land, a public-traded real estate investment trust founded in 1997. It acquires and holds farmland in U.S. major markets and then leases it to third-party farmers. Current ownership of 127 farms in thirteen states is reported by the Company on a quarterly basis. The farm portfolio includes approximately 94,000 acres and is valued at $1.0 billion. Gladstone Land farms tend to be located in areas where tenants can grow fresh fruits and vegetables each year. There are also farms that grow permanent crops such as almonds. Figs. olives. pistachios. Other orchards as well as blueberry and grape groves. These plants can be planted once every 10-20 years. They are harvested each year. Other property that could be acquired by the Company, including cooling and processing buildings, packaging, distribution, or other facilities related to agriculture, may also be purchased. Since its January 2013 initial public offering, the Company has made 93 consecutive cash monthly distributions of its common stock. Over the past 23 quarters, the Company’s common distributions have increased 20 times. The current per-share common stock distribution is $0.0449/month or $0.5388/year.

NASDAQ ended the session with Gladstone Land Corporation sliding 5.66% to $23.15 on Tuesday, following the last session’s upward trend. NASDAQ slid 0.3% to $11,354.62, following the last session’s upward trend on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Gladstone Land Corporation is 833112 which is 115.5% above its average volume of 386578.

Gladstone Land Corporation’s last close was $23.82, 43.42% under its 52-week high of $42.10.

The company’s growth estimates for the current quarter and the next is 41.7% and 20%, respectively.

Gladstone Land Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 50.7%, now sitting on 75.26M for the twelve trailing months.

Gladstone Land Corporation’s Stock Yearly Top and Bottom Value

Gladstone Land Corporation’s stock is valued at $23.15 at 17:33 EST, way below its 52-week high of $42.10 and above its 52-week low of $21.61.

Gladstone Land Corporation’s Moving Average

Gladstone Land Corporation’s worth is way below its 50-day moving average of $35.35 and way below its 200-day moving average of $29.26.

More news about Gladstone Land Corporation.

10. Materialise NV (MTLS) – -5.58%

Materialise NV offers additive manufacturing, medical software and 3D printing services throughout the Americas, Europe, Africa and Asia-Pacific. Materialise Software and Materialise Medical are its three main segments. Materialise Software offers programs and platforms to enhance and enable 3D printing and 3D printer functionality. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. The segment is for 3D printer manufacturers, contract manufacturers, production companies, and consumers goods and hearing aid manufacturers. It also serves 3D printing bureaus via its website, sales force, and distributors. Materialise Medical is a medical segment that provides software for medical imaging and engineering. It also allows patient-specific design and development of surgical devices. Through its website, direct sales force and partner picture archiving, communication and system companies it serves hospitals, universities and other medical devices companies. Materialise Manufacturing provides 3D printing, design, engineering, rapid prototyping, additive manufacturing and production parts for industrial and commercial clients. It has agreements with Zimmer Biomet Holdings, Inc., Encore Medical, L.P., DePuy Synthes Companies Of Johnson & Johnson, Limacorporate Spa, Mathys AG, Corin Ltd., Medtronic Inc., and Abbott Laboratories Inc. Materialise NV was founded in 1990. The company is headquartered at Leuven, Belgium.

NASDAQ ended the session with Materialise NV falling 5.58% to $14.37 on Tuesday while NASDAQ slid 0.3% to $11,354.62.

Volume

Today’s last reported volume for Materialise NV is 232336 which is 9.23% below its average volume of 255988.

Materialise NV’s last close was $15.22, 49.7% under its 52-week high of $30.26.

The company’s growth estimates for the ongoing quarter and the next is a negative 71.4% and a negative 70.6%, respectively.

Materialise NV’s Revenue

Year-on-year quarterly revenue growth grew by 16.3%, now sitting on 212.86M for the twelve trailing months.

Materialise NV’s Stock Yearly Top and Bottom Value

Materialise NV’s stock is valued at $14.37 at 17:33 EST, way below its 52-week high of $30.26 and higher than its 52-week low of $13.40.

Materialise NV’s Moving Average

Materialise NV’s worth is way below its 50-day moving average of $17.83 and way under its 200-day moving average of $20.92.

More news about Materialise NV.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here